ResearcherSamsung Medical CenterActive in the last 2 years
Jeong Il Yu
Matched on ORCID iD 0000-0002-2009-7263; OpenAlex author ID A5008976057. Sources: ClinicalTrials.gov.
Their work
- Papers
- 6 (first author 3, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers, 1 trial · 2026: 1 paper
Papers 6
- Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.acra.2025.10.016↗
- Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. First author DOI 10.1002/jcsm.13643↗
- Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers17182959↗
- Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy. Co-author DOI 10.1016/j.ctro.2024.100732↗
- The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. First author DOI 10.3390/cancers14194556↗
- Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy. First author DOI 10.1177/0300891620937795↗
Trials 1
- PULSAR in Systemic Therapy for Pancreatic Cancer Principal investigator NCT07269626↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Seok Heo · 4 shared papers, 2022–2026 · strength 0.85
- Paper Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ducta… DOI 10.1016/j.acra.2025.10.016↗
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Hee Chul Park · 4 shared papers, 2021–2025 · strength 0.68
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy. DOI 10.1177/0300891620937795↗
- In Woong Han · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Jong Kyun Lee · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Sang Hyun Shin · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Kyu Taek Lee · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Joo Kyung Park · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Joon Oh Park · 3 shared papers, 2022–2025 · strength 0.52
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Paper The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer. DOI 10.3390/cancers14194556↗
- Kwang Hyuck Lee · 2 shared papers, 2024–2026 · strength 0.52
- Paper Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ducta… DOI 10.1016/j.acra.2025.10.016↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Kangpyo Kim · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Ji Hye Min · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Jung Yong Hong · 2 shared papers, 2024–2025 · strength 0.38
- Paper Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer. DOI 10.1002/jcsm.13643↗
- Paper Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer afte… DOI 10.1016/j.ctro.2024.100732↗
- Wonseok Whi · 1 shared paper, 2026 · strength 0.33
- Joon Young Choi · 1 shared paper, 2026 · strength 0.33
- Seung Hyup Hyun · 1 shared paper, 2026 · strength 0.33
- Mi Sook Kim · 1 shared paper, 2025 · strength 0.26
- Won Il Jang · 1 shared paper, 2025 · strength 0.26
- Marta Scorsetti · 1 shared paper, 2025 · strength 0.26
- Sun Hyun Bae · 1 shared paper, 2025 · strength 0.26
- Sook‐Young Woo · 1 shared paper, 2025 · strength 0.20
- Hongbeom Kim · 1 shared paper, 2025 · strength 0.20
- Jin Ho Choi · 1 shared paper, 2025 · strength 0.20
- Kyunga Kim · 1 shared paper, 2024 · strength 0.18
- Tae Hyun Kim · 1 shared paper, 2021 · strength 0.16
- Won Kyung Cho · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.